bullish
Paramount Bed (7817 JP): Poised to Grow on the Back of Recovery from the COVID-19
232 Views18 Jan 2022 00:49
SUMMARY
- Paramount Bed Holdings Co Lt (7817 JP) reported record-high sales and profit during six-month ended on September 30, 2021, driven by strong domestic demand due to recovery from the pandemic.
- Each of businesses are receiving steady inquiries from market and is expected to perform strongly. Management raised full-year guidance after a strong Q1 results.
- New products are driving margin for the company. Nemuri SCAN continues to perform well as remote monitoring using sensor technology is receiving more attention amid the COVID-19 pandemic.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
- Paramount Bed Holdings (7817 JP): In-Line Q1 Result; FY24 Guidance Reaffirmed22 Sep 2023
- Paramount Bed (7817 JP): All-Time Revenue and Profit in FY23; Further Upside Potential Remains14 Jun 2023
- Paramount Bed (7817 JP): Record High Revenue Clocked in FY22; New Management Target Announced09 Jul 2022
- Paramount Bed (7817 JP): Poised to Grow on the Back of Recovery from the COVID-1918 Jan 2022
x